These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15582249)

  • 1. 1,25 Dihydroxyvitamin D(3) receptor expression in superficial transitional cell carcinoma of the bladder: a possible prognostic factor?
    Sahin MO; Canda AE; Yorukoglu K; Mungan MU; Sade M; Kirkali Z
    Eur Urol; 2005 Jan; 47(1):52-7. PubMed ID: 15582249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
    Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
    Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.
    Elsamman E; Fukumori T; Kasai T; Nakatsuji H; Nishitani MA; Toida K; Ali N; Kanayama HO
    BJU Int; 2006 Jun; 97(6):1202-7. PubMed ID: 16686711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
    Zhou JT; Cai ZM; Li NC; Na YQ
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
    Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients.
    Tokunaga H; Lee DH; Kim IY; Wheeler TM; Lerner SP
    Clin Cancer Res; 1999 Sep; 5(9):2520-5. PubMed ID: 10499628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
    Suzuki K; Morita T; Tokue A
    Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
    Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
    Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for mucosal prostatic urethral involvement in superficial transitional cell carcinoma of the bladder.
    Mungan MU; Canda AE; Tuzel E; Yorukoglu K; Kirkali Z
    Eur Urol; 2005 Nov; 48(5):760-3. PubMed ID: 16005563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of angiopoietin-1 and -2, and its clinical significance in human bladder cancer.
    Oka N; Yamamoto Y; Takahashi M; Nishitani M; Kanayama HO; Kagawa S
    BJU Int; 2005 Mar; 95(4):660-3. PubMed ID: 15705099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of estrogen receptor expression in superficial transitional cell carcinoma of the urinary bladder.
    Basakci A; Kirkali Z; Tuzel E; Yorukoglu K; Mungan MU; Sade M
    Eur Urol; 2002 Mar; 41(3):342-5. PubMed ID: 12180239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metallothionein expression as prognostic factor for transitional cell carcinoma of bladder.
    Yamasaki Y; Smith C; Weisz D; van Huizen I; Xuan J; Moussa M; Stitt L; Hideki S; Cherian MG; Izawa JI
    Urology; 2006 Mar; 67(3):530-5. PubMed ID: 16504266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of plasminogen activator inhibitor type 1 expression in bladder cancer.
    Becker M; Szarvas T; Wittschier M; vom Dorp F; Tötsch M; Schmid KW; Rübben H; Ergün S
    Cancer; 2010 Oct; 116(19):4502-12. PubMed ID: 20564745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer.
    Matsumoto K; Satoh T; Irie A; Ishii J; Kuwao S; Iwamura M; Baba S
    Urology; 2008 Aug; 72(2):444-9. PubMed ID: 18313120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of proliferating cell nuclear antigen expression in transitional cell carcinoma of the upper urinary tract.
    Cheng HL; Chow NH; Tzai TS; Tong YC; Lin JS; Chan SH; Yang WH; Chang CC; Lin YM
    Anticancer Res; 1997; 17(4A):2789-93. PubMed ID: 9252716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up.
    Lipponen P; Aaltoma S; Kosma VM; Ala-Opas M; Eskelinen M
    J Pathol; 1998 Oct; 186(2):157-64. PubMed ID: 9924431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications.
    Wang X; Jones TD; Maclennan GT; Yang XJ; Lopez-Beltran A; Eble JN; Koch MO; Lin H; Baldridge LA; Tretiakova M; Cheng L
    Anticancer Res; 2005; 25(3B):2001-4. PubMed ID: 16158936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor-C expression in bladder transitional cell cancer and its relationship to lymph node metastasis.
    Zu X; Tang Z; Li Y; Gao N; Ding J; Qi L
    BJU Int; 2006 Nov; 98(5):1090-3. PubMed ID: 17034609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.